Headquarters
331 S 104TH ST, LOUISVILLE, CO 80027, US
LOUISVILLE, CO, US
From the company
AmideBio discovers peptide therapeutics for metabolic disease, using in-silico design and its proprietary BioPure process to generate ultrapure peptides. Founded in 2009 to commercialize the BioPure platform, it sells peptides directly and offers custom synthesis services, and since 2016 has developed its own therapeutics targeting metabolic diseases, aiming to license drug candidates at or before the IND stage.
331 S 104TH ST, LOUISVILLE, CO 80027, US
Quantities, certifications, and timing.